Novo Nordisk appoints Eddie Li VP
This article was originally published in Scrip
Executive Summary
Novo Nordisk has named Dr Eddie Li vice-president of regulatory affairs, effective 12 September 2011. Dr Li will be reporting to Dr Anne Phillips, corporate vice-president of clinical development, medical and regulatory affairs for North America. He most recently served as global head of regulatory affairs at Sanofi, and has also worked at Johnson & Johnson, AstraZeneca and the FDA.